Jason Kelly - Founder and CEO, Ginkgo Bioworks. Tracked across 40 mentions in podcasts and expert conversations analyzed by Sonic.

Jason Kelly

Co-founder and CEO of Ginkgo Bioworks and business podcast host

Claims

As speaker

Mentioned in

Key positions and views

The traditional biopharma R&D model is fundamentally broken, with less than 5% of spending on value-additive reagents and the vast majority wasted on overhead like personnel and lab space.

AI and robotic automation will fundamentally disrupt science-based industries by enabling a 10x increase in data output per dollar of research spending.

China is rapidly outpacing the United States in key areas of biotechnology innovation, including the speed of clinical trials and the volume of scientific publications.

Major sports franchises and events are undervalued assets that create immense, direct economic benefits for their host cities, justifying high valuations.

Spinning off sports teams from larger parent corporations is a necessary step to provide a clear and transparent proxy for the true market valuation of these assets.

Timeline

2008

Ginkgo Bioworks is founded and operates for six years without raising any venture capital.

2014

Ginkgo Bioworks participates in the Y Combinator accelerator program, marking a shift towards venture funding.

Circa 2021-2024

Kelly observes a surge in the share of new biotech drugs acquired by major pharma that originated in China, growing from less than 5% to over 40%.

Circa 2022-2024

Kelly states that Ginkgo Bioworks strategically shifted its focus from AI-driven biological design to automating physical lab testing to make it cheaper and faster.

June 2024

Kelly discusses the current state of sports business, including massive ticket demand for the upcoming World Cup, high viewership for the NBA Finals, and soaring valuations for WNBA franchises.

Podcast consensus on Kelly

Points of consensus

▶The upcoming World Cup in North America is experiencing unprecedented demand, with claims from two separate episodes stating ticket requests surged to 500 million, a 10x increase over the previous two tournaments combined.Jun 2026

▶Major sporting events, such as the NBA Finals, have a significant, quantifiable economic impact on host cities, with Kelly citing estimates of upwards of half a billion dollars for New York City.Jun 2026

▶AI-powered automation is poised to revolutionize scientific research by dramatically improving efficiency, with Kelly highlighting a collaboration with OpenAI that improved a process by 40% over a state-of-the-art benchmark.May 2026

▶China's role in the global biopharma landscape is rapidly expanding, evidenced by a surge in Chinese-originated drugs being acquired by major firms and significantly faster clinical trial timelines compared to the U.S.

Points of debate

▶Kelly highlights the massive, 500-million-request demand for the World Cup, but also notes that as of early June 2024, 10,000 tickets remained for the US opener, suggesting demand may not be uniformly distributed across all matches.Jun 2026

▶Kelly champions the potential of AI in biological design but states that over the last two years, his company Ginkgo Bioworks has strategically pivoted its focus away from that problem and towards making physical lab testing cheaper and faster.

▶He argues that previous tech revolutions like the internet were 'meaningless' to the biotechnology industry, yet simultaneously predicts that the current AI revolution will fundamentally change how science is done and disrupt the entire biopharma sector.

▶Kelly observes that most U.S. soccer fans prefer the English Premier League over the domestic MLS, yet also details the soaring valuations and high-profile investments in domestic women's sports leagues (WNBA, NWSL), presenting a complex picture of domestic versus international sports interest.Jun 2026

Key themes

▶The Economics of Big-League Sports

Kelly frequently analyzes the business side of professional sports, focusing on franchise valuations, the economic impact of major events like the NBA Finals and World Cup, and the flow of capital into leagues. He emphasizes how events generate hundreds of millions in local economic activity and how new investment vehicles are unlocking value in teams, particularly in women's sports.

For investors, Kelly's analysis suggests that sports assets are an increasingly distinct and valuable class, with valuations that can be made more transparent through corporate actions like spin-offs and are buoyed by massive media viewership and event-driven economic stimulus.

▶AI-Driven Revolution in BiotechnologyMay 2026

A core theme is Kelly's belief that AI and robotic automation are set to overhaul the biotechnology and biopharma industries. He argues that traditional R&D is inefficient and costly, and that autonomous labs can increase data output by 10x per dollar by shifting spending from overhead to reagents.

This theme signals a major platform shift in a multi-billion dollar industry, suggesting that companies providing the underlying automation and AI infrastructure could capture significant value, while traditional life science firms slow to adapt face existential disruption.

▶The Shifting Geopolitics of Scientific R&D

Kelly repeatedly highlights the changing dynamics of global scientific research, particularly the rise of China as a biotech powerhouse. He points to China's faster clinical trials, increased volume of scientific publications, and the growing share of Chinese-originated drugs as evidence that the U.S. is facing significant competition.

This geopolitical lens on R&D indicates that investment strategies and supply chain considerations in the life sciences must now account for China's accelerating innovation cycle, which presents both a competitive threat and a potential source of novel assets for Western firms.

▶Venture Building and Corporate Strategy

Through the lens of his own company, Ginkgo Bioworks, Kelly discusses the practicalities of building a deep-tech company. This includes navigating early-stage funding without VC for years, participating in accelerators like Y Combinator, and making significant strategic pivots, such as shifting focus from AI-driven design to the automation of physical lab work.

Kelly's narrative provides a case study in long-term, capital-intensive venture building, demonstrating that success can require strategic patience (bootstrapping) followed by aggressive scaling and a willingness to pivot core strategy based on market and technological realities.

Source episodes

Suggested prompts

How does Jason Kelly reconcile his view that previous tech revolutions were 'meaningless' to biotech with his conviction that AI will be fundamentally disruptive? &nearr;What are the potential risks or downsides to Ginkgo Bioworks' strategic pivot from AI-driven design to focusing on the automation of physical lab work? &nearr;Given Kelly's commentary on both soaring franchise valuations and the dominance of international leagues like the EPL, what is his long-term outlook on the profitability of domestic US sports leagues? &nearr;How might the rapid acceleration of China's biotech sector, as described by Kelly, impact the intellectual property and M&A strategies of Western pharmaceutical companies? &nearr;

Key concepts

Ginkgo Bioworks 1 ep Biopharma R&D 1 ep AI in Science 1 ep Sports Business 6 ep NBA / New York Knicks 2 ep World Cup / Soccer 3 ep Venture Capital & Startups 1 ep Women's Sports 1 ep US-China Competition 1 ep Economic Impact 1 ep

Notable quotes

“[0:00:16 -> 0:00:24] Like, this is actually going to change the fundamentals of how we do science and our big science industries like biopharma are going to get disrupted.”

Jason Kelly · How Autonomous Labs Will Transform Scientific Research: Ginkgo Bioworks’ Jason Kelly

“[0:16:34 -> 0:16:40] spends less than five percent is on the reagents everything is on overhead it's basically over the people the regulatory the lab space”

Jason Kelly · How Autonomous Labs Will Transform Scientific Research: Ginkgo Bioworks’ Jason Kelly

“We've talked to the, the head of the New York City Economic Development Corporation, who talked about hundreds of millions of dollars, probably upwards of half a billion dollars, maybe more, that are marginally going into the New York City economy.”

Jason Kelly · The Knicks Win! So Does NYC, Big Merch and the NBA | Big Take

“For this one World Cup, this one that's coming up, 500 million ticket requests. So 10x the last two.”

Jason Kelly · Weekend Listen: FIFA’s Jill Ellis on the the World Cup | Big Take

Report last updated: Jul 28, 2026

Create a free account to see Jason Kelly's full intelligence report - every claim, the relationship network, and AI Q&A across all sources. No card needed.

Get started free

Back to Entities Intelligence Report